Jump to:

Guidelines and Clinical Updates


December 2014

NICE recommends dabigatran as an option in thromboembolism

NICE has recommended that dabigatran etexilate (Pradaxa) should be considered as a...

MIMS summary of JBS3 cardiovascular guideline now available

The quick-reference MIMS summary of the Joint British Societies' consensus recommendations for...

BTS/SIGN asthma guidance updated for 2014

The latest edition of the BTS/SIGN guideline on the management of asthma...

NICE rejects MS symptom-relieving treatments

NICE has rejected the NHS use of two treatments indicated to relieve...

November 2014

Alcohol dependence treatment accepted for NHS use

Nalmefene (Selincro) has been recommended by NICE as a possible treatment for...

Interferon beta: risk of thrombotic microangiopathy and nephrotic syndrome

The MHRA has reminded healthcare professionals to be vigilant for signs or...

October 2014

Nitrofurantoin: new advice on use in renal impairment

Nitrofurantoin can now be used in patients with moderate renal impairment.

Change to Yellow Card reporting in children

The MHRA no longer requires all suspected adverse drug reactions (ADRs) in...

MIMs Drug Search

Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.

Find drugs by:

Back to top